Tags: Cancer | keytruda | melanoma | drug | skin | cancer

Drug Fights Advanced Melanoma

Friday, 05 Sep 2014 04:21 PM

Keytruda (pembrolizumab) has been approved by the U.S. Food and Drug Administration to treat advanced melanoma, a deadly form of skin cancer.

Melanoma, accounting for about 5 percent of new cancers in the United States, is expected to be diagnosed in more than 76,000 Americans and about 9,710 are projected to die from it this year, the FDA said in a news release.

Keytruda is the first in a new class of drugs designed to help the body's immune system attack melanoma cells. It's intended to treat people who are no longer responding to other drugs, the FDA said.

The drug was evaluated in a clinical trials involving about 600 people with advanced melanoma whose disease progressed despite treatment. The most common side effects included fatigue, cough, nausea, itchy skin and loss of appetite.

The agency also warned of possible severe immune reactions involving healthy organs including the lung, colon, hormone-producing glands and liver.

© HealthDay

   
1Like our page
2Share
FDA-Approved-Drugs
Keytruda (pembrolizumab) has been approved by the U.S. Food and Drug Administration to treat advanced melanoma, a deadly form of skin cancer. Melanoma, accounting for about 5 percent of new cancers in the United States, is expected to be diagnosed in more than 76,000...
keytruda, melanoma, drug, skin, cancer
154
2014-21-05
Friday, 05 Sep 2014 04:21 PM
Newsmax Inc.
 

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved